18.90
Usana Health Sciences Inc stock is traded at $18.90, with a volume of 78,800.
It is up +2.11% in the last 24 hours and up +9.00% over the past month.
Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).
See More
Previous Close:
$18.51
Open:
$18.59
24h Volume:
78,800
Relative Volume:
0.60
Market Cap:
$348.84M
Revenue:
$925.26M
Net Income/Loss:
$11.48M
P/E Ratio:
33.76
EPS:
0.5599
Net Cash Flow:
$8.53M
1W Performance:
+4.59%
1M Performance:
+9.00%
6M Performance:
-7.85%
1Y Performance:
-21.28%
Usana Health Sciences Inc Stock (USNA) Company Profile
Name
Usana Health Sciences Inc
Sector
Industry
Phone
(801) 954-7100
Address
3838 WEST PARKWAY BLVD., SALT LAKE CITY, UT
Compare USNA vs KHC, JBS, GIS, MKC, HRL
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
USNA
Usana Health Sciences Inc
|
18.90 | 341.64M | 925.26M | 11.48M | 8.53M | 0.5599 |
|
KHC
Kraft Heinz Co
|
22.01 | 26.17B | 24.94B | -5.85B | 3.66B | -4.9384 |
|
JBS
Jbs N V
|
17.75 | 19.35B | 66.64B | 1.80B | 773.23M | 1.7184 |
|
GIS
General Mills Inc
|
34.49 | 18.52B | 18.37B | 2.22B | 1.65B | 4.0676 |
|
MKC
Mccormick Co Inc
|
53.34 | 14.47B | 7.11B | 1.65B | 680.40M | 6.1005 |
|
HRL
Hormel Foods Corp
|
20.66 | 11.42B | 12.14B | 489.00M | 577.53M | 0.8886 |
Usana Health Sciences Inc Stock (USNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-23-23 | Initiated | Sidoti | Buy |
| Jul-07-22 | Downgrade | Jefferies | Hold → Underperform |
| Apr-14-22 | Initiated | DA Davidson | Neutral |
| Dec-17-20 | Initiated | ROTH Capital | Buy |
| Aug-22-19 | Initiated | Jefferies | Hold |
| Apr-16-19 | Initiated | Tigress Financial | Buy |
| Oct-25-18 | Upgrade | Sidoti | Neutral → Buy |
| Oct-24-18 | Upgrade | Pivotal Research Group | Hold → Buy |
| Apr-23-18 | Downgrade | Pivotal Research Group | Buy → Hold |
| Feb-07-18 | Reiterated | Pivotal Research Group | Buy |
| Jan-24-18 | Downgrade | Sidoti | Buy → Neutral |
| Oct-25-17 | Reiterated | Pivotal Research Group | Buy |
| Jul-26-17 | Reiterated | Pivotal Research Group | Buy |
| May-03-17 | Upgrade | Pivotal Research Group | Hold → Buy |
| May-01-17 | Downgrade | Pivotal Research Group | Buy → Hold |
| Feb-08-17 | Reiterated | Pivotal Research Group | Buy |
| Jul-28-16 | Reiterated | DA Davidson | Neutral |
| Feb-10-16 | Downgrade | DA Davidson | Buy → Neutral |
| Oct-16-15 | Upgrade | Sidoti | Neutral → Buy |
| Sep-16-15 | Upgrade | DA Davidson | Neutral → Buy |
| Aug-06-15 | Downgrade | DA Davidson | Buy → Neutral |
| Aug-05-15 | Upgrade | Pivotal Research Group | Hold → Buy |
| Jun-26-15 | Initiated | DA Davidson | Buy |
View All
Usana Health Sciences Inc Stock (USNA) Latest News
USANA Health Sciences (NYSE:USNA) Raised to "Strong-Buy" at Zacks Research - MarketBeat
USANA Schedules First Quarter 2026 Earnings Release and Conference Call - FinancialContent
Published on: 2026-04-14 00:02:07 - baoquankhu1.vn
USANA Health Sciences Experiences Revision in Its Stock Evaluation Amid Mixed Performance Metrics - Markets Mojo
Aug Spikes: Is USANA Health Sciences Inc stock influenced by commodity prices2026 EndofYear Setup & Stock Portfolio Risk Management - baoquankhu1.vn
[ARS] USANA HEALTH SCIENCES INC SEC Filing - Stock Titan
USANA (NYSE: USNA) details 2026 virtual meeting, board and pay votes - Stock Titan
USANA Health Sciences, Inc. (USNA) Stock forecasts - Yahoo Finance UK
USANA Health Sciences Announces Record Second Quarter Financial Results - Yahoo
Market Recap: What is the target price for USANA Health Sciences Inc stock2026 Momentum & Fast Gain Swing Trade Alerts - baoquankhu1.vn
USANA CEO Kevin Guest Calls for Daily Health Routines on World Health Day - Sahm
Published on: 2026-04-02 10:27:50 - baoquankhu1.vn
USANA Health (USNA) Loses 16.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Eastern Progress
Each book sale funds 40 meals as USANA CEO pushes daily habits - Stock Titan
Major USANA (USNA) holder Wentz updates 40.1% ownership via Gull Global - Stock Titan
Vanguard (USNA) amendment shows 0 shares; subsidiaries report separately - Stock Titan
Published on: 2026-03-27 12:44:15 - baoquankhu1.vn
Aug Spikes: Will USANA Health Sciences Inc outperform during market rallies2026 Price Swings & Detailed Earnings Play Strategies - baoquankhu1.vn
Tested, Trusted, Approved: USANA CellSentials Earns ConsumerLab.com Seal of Approval for Purity and Potency - Finviz
Third-party tests clear USANA supplement on purity and potency - Stock Titan
Fuller sells USANA [USNA] shares worth $17986 By Investing.com - Investing.com Australia
Insider Selling: USANA Health Sciences (NYSE:USNA) Director Sells 1,058 Shares of Stock - MarketBeat
Fuller sells USANA [USNA] shares worth $17986 - Investing.com
USANA (USNA) director Gilbert Fuller sells 1,058 shares, now holds none - Stock Titan
USANA Health Sciences Experiences Valuation Adjustment Amidst Competitive Market Dynamics - Markets Mojo
Loss Report: Will USANA Health Sciences Inc outperform during market ralliesQuarterly Growth Report & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn
USANA Health Sciences 2025-2026 Business Overview: Core Nutritional, Direct-to-Consumer Segments, Product Lines, and Growth Strategy 40414243444546 - minichart.com.sg
USANA Health Sciences: $925.3M Revenue, $0.58 Diluted EPS in 10-K - TradingView
USANA (NYSE: USNA) outlines 2025 sales, China exposure and Hiya expansion - Stock Titan
USANA Health Sciences : Annual Report for Fiscal Year Ending January 3, 2025 (Form 10-K) - marketscreener.com
USANA Health Sciences Hits New 52-Week Low at $16.71 - Markets Mojo
USANA outlines 4% sales growth target for 2026 amid omnichannel and product innovation push - MSN
Published on: 2026-03-07 21:51:28 - baoquankhu1.vn
USANA Health Sciences Hits 52-Week Low at $18.04 Amid Ongoing Struggles - Markets Mojo
5 Low P/B Ratio Stocks That You May Consider Buying in March - TradingView
QURE Stock Crashes 32% in a Week: Here's What You Should Know - Finviz
USANA Launches Celavive Postbiotic Skincare in PHL - BusinessMirror
USANA Health (USNA) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Finviz
CANF Stock Soars 20% on Positive Mid-Stage Pancreatic Cancer Data - Finviz
USANA Looks Like An Undervalued Turnaround Stock (NYSE:USNA) - Seeking Alpha
ACAD Plans Re-Examination After CHMP Rejects Rett Syndrome Drug in EU - Finviz
CORRECTING and REPLACING USANA Announces Management Team Transition - AOL.com
Usana Health Sciences CIO Benedict Peter sells $88,258 in stock - Investing.com
Usana Health Sciences CIO Benedict Peter sells $88,258 in stock By Investing.com - Investing.com Canada
Insider Sell: Peter Benedict Sells 4,553 Shares of Usana Health Sciences Inc (USNA) - GuruFocus
USANA (USNA) CIO Benedict sells 4,553 shares in open-market trade - Stock Titan
USNA Financials: Income Statement, Balance Sheet & Cash Flow | Usana Health Sciences Inc - Stock Titan
USANA (USNA) COO exercises 7,422 RSUs and withholds 3,144 shares for taxes - Stock Titan
USANA Health Sciences (USNA) CCO nets shares after RSU vesting and tax withholding - Stock Titan
USANA (USNA) executive converts RSUs, withholds 1,349 shares for tax - Stock Titan
USANA Health Sciences (USNA) CFO exercises RSUs, disposes shares for taxes - Stock Titan
Usana Health Sciences Inc Stock (USNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Usana Health Sciences Inc Stock (USNA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Benedict Peter | CHIEF INFORMATION OFFICER |
Mar 03 '26 |
Sale |
19.38 |
4,553 |
88,259 |
0 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):